Monday, May 18, 2020

Teva Pharm Gets Approval in China for Huntington's Treatment


By Reuters
NYT World
China has given the greenlight to Teva Pharmaceutical Industries' Austedo treatment for Huntington's disease, the company said on Monday.
Published date: May 18, 2020 at 11:10AM
Reuters
New York Times article

No comments:

Post a Comment